Minister of Industry, Investment and Commerce, Anthony Hylton, says Jamaica intends to lead a charge in the United Nations to effect changes to the international treaties concerning marijuana. The aim is to change the schedule class of marijuana in light of scientific studies that have proven its therapeutic benefits and medicinal value. "Jamaica intends to participate, and to lead, if necessary, a process in the United Nations to have those treaties amended," Hylton said.
The United Nations Development Programme (UNDP), the UN agency charged with developing strategies to reduce global poverty, has strongly criticised current international drug policy, highlighting the disastrous costs it is producing – particularly for the world’s poor. In the agency’s formal submission to the UN General Assembly Special Session (UNGASS) on drugs (PDF), launched at the annual UN Commission on Narcotic Drugs which began last week in Vienna, the UNDP argues:
The “E-Book of Authorities” is a civil society-led project to catalogue agreed UN statements and language on a selection of key topics. It aims to show the extent of existing international support for evidence-based drug policies, and to support international drug policy discussions, debates and negotiations.
Mozart Room (in the Restaurant), Vienna International Centre
In recent years, the Americas have been at the forefront of calls for a meaningful review of traditional approaches to drug control based on tough law enforcement and incarceration. The region has borne many of the costs of this approach, including enduring prison overcrowding, violence, and the proliferation of organised criminal organisations. Past policies have caused considerable health and social harms as well. Forced crop eradication programmes have only contributed to cycles of poverty and punitive responses to drug consumption have expanded in lieu of public health approaches.
The UN General Assembly Special Session (UNGASS) on drugs is fast approaching 2016 and is an important opportunity to conduct a thorough and objective assessment of the international drug control system. This session will discuss remaining challenges, as well as opportunities for the way forward – in particular towards rebalancing current drug policies towards the core UN values of public health, human rights and development
In a dispute that pits the war on drugs against global health needs — and one UN agency against another — a pair of Canadian researchers is spearheading a last-ditch bid to keep a widely used anesthetic from being declared an illicit narcotic.
The Commission on Narcotic Drugs (CND) in Vienna will decide next week between two opposite proposals by China and the WHO about international control of ketamine, an essential anaesthetic in human and veterinary medicine. China originally proposed bringing ketamine under the 1971 Convention’s most severe control regime of Schedule I, which would dramatically affect its availability for surgery in poor rural settings and emergency situations. The WHO Expert Committee reviewed all the evidence and advised against any international control of ketamine, arguing it would trigger a public health disaster.
The Annual Report of the International Narcotics Control Board (INCB), released today, calls upon States that ‘continue to impose the death penalty for drug-related offences to consider abolishing the death penalty for such offences’.
A proposal that is about to come before the UN to restrict global access to ketamine, a drug abused in rich countries, would deprive millions of women of lifesaving surgery in poor countries, according to medicines campaigners.
As the call for the decriminalisation of drugs steadily picks up steam worldwide, a new study by the London-based charity Health Poverty Action concludes there has been no significant reduction in the global use of illicit drugs since the creation of three key U.N. anti-drug conventions, the first of which came into force over half a century ago. “Illicit drugs are now purer, cheaper, and more widely used than ever,” says the report, titled Casualties of War: How the War on Drugs is Harming the World’s Poorest.
In April 2016, representatives of the world’s nations will gather to evaluate drug policy in a United Nations General Assembly Special Session (UNGASS). While prohibitionist policies are still the norm, a rising tide of voices are demanding evidence based responses that respect human rights, promote public health, and reduce crime.
The UN Commission considers to bring ketamine under the control of the 1971 Convention on Psychotropic Substances contrary to WHO recommendations. The 58th Session of the UN Commission on Narcotic Drugs (CND) in March 2015 has been asked to consider a Chinese proposal to place ketamine – an essential medicine used for anaesthesia – in Schedule I of the 1971 Convention (E/CN.7/2015/7 and E/CN.7/2015/81). Ketamine is the only available anaesthetic for essential surgery in most rural areas of developing countries, home to more than 2 billion of the world’s people. Scheduling ketamine under any of the 1971 treaty schedules will reduce its availability and further deepen the already acute crisis of global surgery.
Ketamine is an essential medicine used for anaesthesia. It is the only available anaesthetic for essential surgery in most rural areas of developing countries, home to more than 2 billion of the world’s people. Scheduling ketamine will leave these populations with no alternative anaesthesia for essential surgery, and will further deepen the already acute crisis of global surgery.
UN forums in recent years have witnessed more and more governments expressing their frustrations with the failing global war on drugs. This failure goes way beyond just the goals of drug control systems to reduce illicit drug production and use. The key driver of calls for change has been the catastrophic negative impacts of the war on drugs on public health, human rights, development and security.